Screening for atrial fibrillation: less is more?

We have been accepted for the very exciting Bayer G4A partnerships Program for 2021" We are very proud and excited in being selected by Bayer as one of the Finalists of this year's G4A Growth.

Cardiokol was selected by Bayer from over 200 applications across 40 countries based on strategic fit, development stage of the project, and rigorous internal assessment.

Cardiokol is amongst four promising digitalhealth companies that will receive funding to accelerate market uptake as well as mentorship from Bayer experts and coaching from external industry experts in various fields.

Congratulations to the Cardiokol team on this incredible accomplishment, we will continue to develop life-changing technology using the power of voice to save lives.

We are proud to be presenting this year’s  Growth Track finalists which will take part in the G4A Digital Health Partnerships Program.

These four promising digital health companies in the areas of cardiovascular diseases, women’s health, and mental health will receive 100.000 EUR funding to accelerate market uptake as well as mentorship from Bayer experts and coaching from external industry experts in various fields.

The companies were selected by Bayer from over 200 applications out of 40 countries based on the strategic fit, development stage of the project, and internal assessment. Thank you to all of the companies that applied for our Partnerships Program this year! Stay tuned: We will announce this year’s Advance Track partners that will enter commercial partnerships with Bayer end of September.

‍This year’s selected Growth Track partners are:

Acorai develops a non-invasive, cost-efficient cardiac pressure monitoring device to reduce heart failure re-hospitalizations. The Acorai Heart Monitor can detect impending heart failure before visible symptoms appear.

Cardiokol develops a voice-based, hardware-free solution for monitoring and screening of heart arrythmias in order to prevent stroke and heart diseases and improve monitoring for at-risk populations.

Pollie develops the one-stop-shop telehealth solution for the management of complex women’s chronic conditions by offering a personalized, digital program for women to manage PCOS, the most common hormone imbalance in women.

‍RCube Health develops RESONY, an app that provides instant access to evidence-based mental health support. RESONY offers personalized exercises to reduce daily stress and anxiety.

G4A GROWTH TRACK

FINALISTS 2021